BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
US Army
Fuji
Medtronic
Argus Health
Citi
Daiichi Sankyo
Federal Trade Commission
Cantor Fitzgerald
Accenture

Generated: January 17, 2018

DrugPatentWatch Database Preview

Granisetron hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for granisetron hydrochloride and what is the scope of granisetron hydrochloride patent protection?

Granisetron hydrochloride
is the generic ingredient in four branded drugs marketed by Akorn Inc, Aurobindo Pharma Ltd, Baxter Hlthcare Corp, Bionpharma Inc, Cipla Ltd, Fresenius Kabi Usa, Hikma Farmaceutica, Luitpold, Mylan Labs Ltd, Sagent Agila, Sagent Strides, Sandoz Inc, Teva Pharms Usa, West-ward Pharms Int, Wockhardt Usa, Roche, Pediatrx, Apotex Inc, Barr, Dr Reddys Labs Ltd, Epic Pharma Llc, Mylan, Natco Pharma, Orchid Hlthcare, Taro Pharm, and Teva Pharms, and is included in forty-eight NDAs. There is one patent protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Granisetron hydrochloride has twenty-six patent family members in nineteen countries.

There are twenty-six drug master file entries for granisetron hydrochloride. Eighteen suppliers are listed for this compound.
Summary for granisetron hydrochloride
Pharmacology for granisetron hydrochloride

US Patents and Regulatory Information for granisetron hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pediatrx GRANISOL granisetron hydrochloride SOLUTION;ORAL 078334-001 Feb 28, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cipla Ltd GRANISETRON HYDROCHLORIDE granisetron hydrochloride TABLET;ORAL 078037-001 Feb 27, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa GRANISETRON HYDROCHLORIDE granisetron hydrochloride INJECTABLE;INJECTION 078090-001 Jun 30, 2008 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int GRANISETRON HYDROCHLORIDE granisetron hydrochloride TABLET;ORAL 077842-001 Dec 31, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sagent Strides GRANISETRON HYDROCHLORIDE granisetron hydrochloride INJECTABLE;INJECTION 091136-001 Apr 9, 2010 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int GRANISETRON HYDROCHLORIDE granisetron hydrochloride INJECTABLE;INJECTION 077187-001 Jun 30, 2008 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan GRANISETRON HYDROCHLORIDE granisetron hydrochloride TABLET;ORAL 078725-001 Jan 30, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride INJECTABLE;INJECTION 020239-004 Mar 11, 1994 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc GRANISETRON HYDROCHLORIDE granisetron hydrochloride INJECTABLE;INJECTION 078835-002 Jun 30, 2008 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Akorn Inc GRANISETRON HYDROCHLORIDE granisetron hydrochloride INJECTABLE;INJECTION 079119-001 Sep 10, 2009 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for granisetron hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche KYTRIL granisetron hydrochloride INJECTABLE;INJECTION 020239-001 Dec 29, 1993 ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride INJECTABLE;INJECTION 020239-003 Sep 17, 2004 ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride SOLUTION;ORAL 021238-001 Jun 27, 2001 ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride INJECTABLE;INJECTION 020239-004 Mar 11, 1994 ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride INJECTABLE;INJECTION 020239-002 Mar 11, 1994 ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride INJECTABLE;INJECTION 020239-001 Dec 29, 1993 ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride INJECTABLE;INJECTION 020239-004 Mar 11, 1994 ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride TABLET;ORAL 020305-002 Jun 15, 1998 ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride INJECTABLE;INJECTION 020239-002 Mar 11, 1994 ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride TABLET;ORAL 020305-001 Mar 16, 1995 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for granisetron hydrochloride

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Julphar
Daiichi Sankyo
Fuji
Johnson and Johnson
Moodys
US Department of Justice
Harvard Business School
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot